Reference is made to the stock exchange announcement published by
The share capital increases pertaining to the issuance of the 137,193,548
The Company's registered share capital is
For further information, please contact:
Mobile: +47 916 24 683
E-mail: rune.nystad@observemedical.com
Per Arne Nygård, CFO Observe Medical
Mobile: +47 411 04 345
E-mail: perarne.nygard@observemedical.com
About
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care, in combination with targeted M&A.
The Company is headquartered in
Further information is available at www.observemedical.com.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
https://news.cision.com/observe-medical-asa/r/observe-medical-asa---new-share-capital-registered,c3897525
https://mb.cision.com/Main/19175/3897525/2511629.pdf
(c) 2023 Cision. All rights reserved., source